Diasorin | DIA - Ebitda

Stock Price
70.00
Daily Change
-0.22 -0.31%
Monthly
-1.24%
Yearly
-30.21%
Q1 Forecast
68.08

Diasorin reported EUR87M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Amplifon EUR 107.33M 38.85M Sep/2025
Avanos Medical USD 10M 73.9M Sep/2025
Brookdale Senior Living USD 111.07M 1.58M Sep/2025
Cencora USD 1.16B 116.6M Sep/2025
Diasorin EUR 87M 10M Sep/2025
Encompass Health USD 335.6M 35.5M Dec/2025
Enovis USD 94.8M 2.4M Sep/2025
GE HealthCare Technologies USD 909M 35M Sep/2025
OPKO Health USD 75.53M 144.7M Sep/2025
Pediatrix Medical Group USD 49.48M 7.96M Sep/2023
Veradigm USD 38.81M 29.61M Sep/2022
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025